Porsteinsson A - Search Results

1

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales.

Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S. Tariot PN, et al. Among authors: porsteinsson a. Adv Drug Deliv Rev. 2002 Dec 7;54(12):1567-77. doi: 10.1016/s0169-409x(02)00153-9. Adv Drug Deliv Rev. 2002. PMID: 12453674 Review.

2

Treating Alzheimer's disease. Pharmacologic options now and in the near future.

Tariot PN, Schneider L, Porsteinsson AP. Tariot PN, et al. Among authors: porsteinsson ap. Postgrad Med. 1997 Jun;101(6):73-6, 81, 84 passim. doi: 10.3810/pgm.1997.06.224. Postgrad Med. 1997. PMID: 9194867

3

An open trial of valproate for agitation in geriatric neuropsychiatric disorders.

Porsteinsson AP, Tariot PN, Erb R, Gaile S. Porsteinsson AP, et al. Am J Geriatr Psychiatry. 1997 Fall;5(4):344-51. doi: 10.1097/00019442-199700540-00010. Am J Geriatr Psychiatry. 1997. PMID: 9363292 Free article. Review.

4

Treatment of agitation in dementia.

Tariot P, Gaile SE, Castelli NA, Porsteinsson AP. Tariot P, et al. Among authors: porsteinsson ap. New Dir Ment Health Serv. 1997 Winter;(76):109-23. doi: 10.1002/yd.2330247610. New Dir Ment Health Serv. 1997. PMID: 9520529 Review.

5

Placebo-controlled study of divalproex sodium for agitation in dementia.

Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, Noviasky J, Kowalski N, Holt CJ, Irvine C. Porsteinsson AP, et al. Am J Geriatr Psychiatry. 2001 Winter;9(1):58-66. Am J Geriatr Psychiatry. 2001. PMID: 11156753 Clinical Trial.

6

Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.

Tariot PN, Ryan JM, Porsteinsson AP, Loy R, Schneider LS. Tariot PN, et al. Among authors: porsteinsson ap. Clin Geriatr Med. 2001 May;17(2):359-76. doi: 10.1016/s0749-0690(05)70073-2. Clin Geriatr Med. 2001. PMID: 11375140 Review.

7

Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.

Porsteinsson AP, Tariot PN, Jakimovich LJ, Kowalski N, Holt C, Erb R, Cox C. Porsteinsson AP, et al. Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):434-40. Am J Geriatr Psychiatry. 2003. PMID: 12837672 Clinical Trial.

8

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group. Tariot PN, et al. Among authors: porsteinsson a. Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9. doi: 10.1176/appi.ajgp.13.11.942. Am J Geriatr Psychiatry. 2005. PMID: 16286437 Clinical Trial.

9

A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease.

Profenno LA, Jakimovich L, Holt CJ, Porsteinsson A, Tariot PN. Profenno LA, et al. Among authors: porsteinsson a. Curr Alzheimer Res. 2005 Dec;2(5):553-8. doi: 10.2174/156720505774932205. Curr Alzheimer Res. 2005. PMID: 16375658 Clinical Trial.

10

Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.

Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC. Siemers ER, et al. Among authors: porsteinsson a. Neurology. 2006 Feb 28;66(4):602-4. doi: 10.1212/01.WNL.0000198762.41312.E1. Neurology. 2006. PMID: 16505324 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page